Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Rob who wrote (1111)	11/5/1998 8:32:00 PM
From: Chuca Marsh	Respond to of 1501

One more just came out: ( It IS going North- reminds of the week I bot many thousands of dollars of IZPs for the first time after reading Neil Maedel and Copley Pacific out of Texas( why aren't they mentioned they got Big K $s I heard <USDs>) and THEN I go to call the company for the first time-they moved- an SNAFU #1- Dr or someone let the phone get DISCONNECTED!) ...they didn't deal correctly Many old fronts of confusions. From: newsout@canada-stockwatch.com Date: Thu, 05 Nov 1998 17:13:38 -0800 Subject: Stockwatch: Inflazyme Pharmaceuticals Ltd - In the News Globe says CFO objects to Internet tout story Inflazyme Pharmaceuticals Ltd IZP Shares issued 24,997,493 Nov 5 close $0.50 Thu 5 Nov 98 In the News The Globe and Mail reports in its Thursday edition that Canada Stockwatch has landed in trouble with one of its story subjects. VSE Watch columnist Ann Gibbon says that Inflazyme Pharmaceuticals alleges that a headline suggested it is the subject of a United States Securities and Exchange Commission investigation. The article described the failure of a company called Core Communications and its prinipal, Joshua Levine, to disclose it was being paid to do investor relations work for Inflazyme. The contract with Core and Inflazyme ended in January, 1997, as the story made clear, and Inflazyme says it has not been associated with Core since. The Globe notes that Inflazyme chief financial officer Michael Liggett claims the headline made it sound like Inflazyme was part of the SEC investigation, which is not the case. The Globe says the SEC was conducting its investigation of stock promotion over the Internet, where there is considerable growth in the illegal promotion of small company stocks. (c) Copyright 1998 Canjex Publishing Ltd. canada-stockwatch.com